These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 18444925)

  • 21. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
    Hu RH; Ho MC; Wu YM; Yu SC; Lee PH
    Clin Transplant; 2005 Apr; 19(2):175-80. PubMed ID: 15740552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors for salvage liver transplantation.
    Lee S; Hyuck David Kwon C; Man Kim J; Joh JW; Woon Paik S; Kim BW; Wang HJ; Lee KW; Suh KS; Lee SK
    Liver Transpl; 2014 Sep; 20(9):1057-63. PubMed ID: 24862741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
    Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 25. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.
    de Haas RJ; Lim C; Bhangui P; Salloum C; Compagnon P; Feray C; Calderaro J; Luciani A; Azoulay D
    Hepatology; 2018 Jan; 67(1):204-215. PubMed ID: 28806477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrence of hepatocellular cancer after liver transplantation: the role of primary resection and salvage transplantation in East and West.
    Lai Q; Avolio AW; Lerut J; Singh G; Chan SC; Berloco PB; Tisone G; Agnes S; Chok KS; Sharr W; Rossi M; Manzia TM; Lo CM
    J Hepatol; 2012 Nov; 57(5):974-9. PubMed ID: 22771712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Transplantation for High Risk Hepatocellular Carcinoma After Liver Resection: A Sequential or Salvage Approach?
    Lin CC; Elsarawy AM; Li WF; Lin TL; Yong CC; Wang SH; Wang CC; Kuo FY; Cheng YF; Chen CL
    Ann Transplant; 2017 Oct; 22():602-610. PubMed ID: 28993607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison.
    Yoon YI; Song GW; Lee S; Moon D; Hwang S; Kang WH; Cho HD; Ha SM; Kim MJ; Kim SH; Na BG; Yang G; Min Kim S; Hyun Shim J; Park JI
    Am J Transplant; 2022 Jan; 22(1):165-176. PubMed ID: 34383368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival after radiofrequency ablation and salvage transplantation in patients with hepatocellular carcinoma and Child-Pugh A cirrhosis.
    N'Kontchou G; Aout M; Laurent A; Nahon P; Ganne-Carrié N; Grando V; Baghad I; Roulot D; Trinchet JC; Sellier N; Cherqui D; Vicaut E; Beaugrand M; Seror O
    J Hepatol; 2012 Jan; 56(1):160-6. PubMed ID: 21703186
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principle.
    Foltys D; Zimmermann T; Kaths M; Strempel M; Heise M; Hoppe-Lotichius M; Weiler N; Scheuermann U; Ruckes C; Hansen T; Pitton M; Otto G
    Clin Transplant; 2014 Jan; 28(1):37-46. PubMed ID: 24171713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.
    Lim C; Goumard C; Casellas-Robert M; Lopez-Ben S; Lladó L; Busquets J; Salloum C; Albiol-Quer MT; Castro-Gutiérrez E; Rosmorduc O; Feray C; Ramos E; Figueras J; Scatton O; Azoulay D
    World J Surg; 2020 Jun; 44(6):1966-1974. PubMed ID: 32095855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.
    Meyerovich G; Goykhman Y; Nakache R; Nachmany I; Lahat G; Shibolet O; Menachem Y; Katchman H; Wolf I; Geva R; Klausner JM; Lubezky N
    Transplant Proc; 2019; 51(6):1867-1873. PubMed ID: 31399171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival according to recurrence patterns after resection for transplantable hepatocellular carcinoma in HBV endemic area: Appraisal of liver transplantation strategy.
    Seo CG; Yim SY; Um SH; Lee YR; Lee YJ; Kim TH; Goh HG; Lee YS; Suh SJ; Han NY; Choi HS; Kim ES; Keum B; Seo YS; Yim HJ; Kim JH; Kim DS; Jeen YT; Chun HJ; Lee HS; Kim CD
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):532-542. PubMed ID: 31870653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MTM-HCC at Previous Liver Resection as a Predictor of Overall Survival in Salvage Liver Transplantation.
    Yang Y; Sun JH; Tan XY; Lu CD; Huang ZP; Zhu HD; Shi XT; Chen JX; Fang JZ
    Dig Dis Sci; 2023 Jun; 68(6):2768-2777. PubMed ID: 36790686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical behavior of transplantable recurrent hepatocellular carcinoma after curative resection: implications for salvage liver transplantation.
    Lee HS; Choi GH; Joo DJ; Kim MS; Choi JS; Kim SI
    Ann Surg Oncol; 2014 Aug; 21(8):2717-24. PubMed ID: 24916744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy.
    Lei JY; Yan LN; Wang WT
    World J Gastroenterol; 2013 Jul; 19(27):4400-8. PubMed ID: 23885153
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salvage liver transplantation for patients with recurrent hepatocellular carcinoma after curative resection.
    Wu L; Hu A; Tam N; Zhang J; Lin M; Guo Z; He X
    PLoS One; 2012; 7(7):e41820. PubMed ID: 22848619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liver Resection for Solitary Transplantable Hepatocellular Carcinoma: The Role of AFP-Score.
    Menahem B; Duvoux C; Ganne N; Mallat A; Seror O; Calderaro J; Launoy G; Alves A; Cherqui D; Luciani A; Laurent A
    World J Surg; 2019 Jan; 43(1):221-229. PubMed ID: 30128773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in patients with recurrent hepatocellular carcinoma treated with salvage liver transplantation: a single-center study.
    Wang P; Li H; Shi B; Que W; Wang C; Fan J; Peng Z; Zhong L
    Oncotarget; 2016 Jun; 7(23):35071-83. PubMed ID: 27145461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes following aggressive management of recurrent hepatocellular carcinoma after upfront liver resection.
    Tranchart H; Chirica M; Sepulveda A; Massault PP; Conti F; Scatton O; Soubrane O
    World J Surg; 2012 Nov; 36(11):2684-91. PubMed ID: 22851144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.